# Remote outcome measures in Alzheimer's disease clinical trials: A call to action

**Authors:** Gustavo A. Jimenez-Maggiora

PMC · DOI: 10.1016/j.tjpad.2026.100528 · The Journal of Prevention of Alzheimer's Disease · 2026-02-27

## Full-text entities

- **Diseases:** depression (MESH:D003866), sleep disruption (MESH:D019958), cognitive decline (MESH:D003072), neuropsychiatric symptoms (MESH:D001523), AD (MESH:D000544), agitation (MESH:D011595), COVID-19 (MESH:D000086382)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12964280/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12964280/full.md

---
Source: https://tomesphere.com/paper/PMC12964280